Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Inhalation-type pharmaceutical composition for the treatment of kidney disease and preparation method thereof

An inhalation and composition technology, applied in the field of inhalation pharmaceutical composition and its preparation, to achieve the effect of increasing the therapeutic effect of drug absorption

Inactive Publication Date: 2015-11-04
林信涌
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the above-mentioned drugs still have obvious side effects in clinical application.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Inhalation-type pharmaceutical composition for the treatment of kidney disease and preparation method thereof
  • Inhalation-type pharmaceutical composition for the treatment of kidney disease and preparation method thereof
  • Inhalation-type pharmaceutical composition for the treatment of kidney disease and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0024] In order to make the advantages, spirit and characteristics of the present invention more easily and clearly understood, the following will be described and discussed in detail with reference to the accompanying drawings. It should be noted that these embodiments are only representative embodiments of the present invention, and the specific methods, devices, conditions, materials, etc. exemplified therein are not intended to limit the present invention or the corresponding embodiments.

[0025] The invention proposes an inhalation pharmaceutical composition for treating kidney diseases, which includes a first gas and atomized medicinal liquid. The first gas contains hydrogen, and the concentration of hydrogen in gas volume of the inhalation pharmaceutical composition is between 2% and 96%. The nebulized medicinal liquid contains one or a combination selected from the group consisting of corticosteroids, angiotensin-converting enzyme inhibitors, angiotensin II receptor b...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides an inhalation-type pharmaceutical composition for kidney disease and preparation method thereof, comprising a first gas and an atomized medicine. The first gas comprises hydrogen. The gas volume concentration of hydrogen in the inhalation-type pharmaceutical composition is between 2 to 96%. The atomized medicine is selected from a group comprising corticosteroid, angiotensin converting enzyme inhibitor, angiotensin II receptor blocker, diuretics, erythropoietin, phosphate binding agent, and any combination thereof. The inhalation-type pharmaceutical composition of the present invention can remove harmful radicals in the body of the patient through the use of hydrogen while also increases the absorption effect of the medicine for the patient by using an atomized medicine. At the same time, because the use of the small amount of the vaporized pharmaceutical liquid can indirectly reduce the side effects on the user.

Description

technical field [0001] The invention relates to an inhalation pharmaceutical composition and a preparation method thereof, in particular to an inhalation pharmaceutical composition for treating kidney diseases and a preparation method thereof. Background technique [0002] Kidney disease includes nephritis, nephropathy, renal insufficiency, etc., and the main symptoms are proteinuria, edema, high blood pressure, hematuria, and renal function decline. Furthermore, most patients need to rely on dialysis treatment to maintain their lives once their kidney disease develops to the end stage. However, long-term dialysis requires huge medical expenses, which has a great impact on the patient's economy and life. [0003] At present, the clinical treatment of kidney disease is mostly used, such as: corticosteroid (Corticosteroid), also known as adrenal cortex, has anti-inflammatory and immune system effects, and is an important drug for the treatment of nephrotic syndrome and other ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/72A61K45/00A61P13/12
CPCA61K9/0073A61K31/573A61K47/02A61K31/00A61K38/1816A61K9/008A61P13/12
Inventor 林信涌
Owner 林信涌
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products